1. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway
   JIE-RU CHEN et al, 2016, International Journal of Oncology CrossRef
2. Meta analysis of bioactive compounds, miRNA, siRNA and cell death regulators as sensitizers to doxorubicin induced chemoresistance
   Sruthi Sritharan et al, 2022, Apoptosis CrossRef
3. Piperlongumine induces apoptosis and G2/M phase arrest in human osteosarcoma cells by regulating ROS/PI3K/Akt pathway
   Jinfeng Zhou et al, 2020, Toxicology in Vitro CrossRef
4. Harmine and Piperlongumine Revert TRIB2-Mediated Drug Resistance
   Susana Machado et al, 2020, Cancers CrossRef
5. Overview of piperlongumine analogues and their therapeutic potential
   Peng Zhu et al, 2021, European Journal of Medicinal Chemistry CrossRef
6. Convallatoxin Inhibits Cell Proliferation and Induces Cell Apoptosis by Attenuating the Akt-E2F1 Signaling Pathway in K562 Cells
   Man Li et al, 2022, Natural Product Communications CrossRef
7. Reversal of cisplatin resistance in oral squamous cell carcinoma by piperlongumine loaded smart nanoparticles through inhibition of Hippo-YAP signaling pathway
   Pratikshya Sa et al, 2024, Translational Research CrossRef
8. Synergistic anticancer activity of doxorubicin and piperlongumine on DU-145 prostate cancer cells – The involvement of carbonyl reductase 1 inhibition
   Kamil Piska et al, 2019, Chemico-Biological Interactions CrossRef
9. Piperlongumine inhibits cancer stem cell properties and regulates multiple malignant phenotypes in oral cancer
   Yin‑Ju Chen et al, 2017, Oncology Letters CrossRef
10. Piplartine (piperlongumine), oxidative stress, and use in cancer
    Daniel Pereira Bezerra, 2021, Cancer CrossRef
11. Let-7d increases ovarian cancer cell sensitivity to a genistein analog by targeting c-Myc
    Ying-Xia Ning et al, 2017, Oncotarget CrossRef
12. N-myristoylation of Antimicrobial Peptide CM4 Enhances Its Anticancer Activity by Interacting With Cell Membrane and Targeting Mitochondria in Breast Cancer Cells
    Caiyun Li et al, 2018, Frontiers in Pharmacology CrossRef
13. A novel platinum complex containing a piplartine derivative exhibits enhanced cytotoxicity, causes oxidative stress and triggers apoptotic cell death by ERK/p38 pathway in human acute promyelocytic leukemia HL-60 cells
    Maiara de S. Oliveira et al, 2019, Redox Biology CrossRef
14. Quercetin reverses the doxorubicin resistance of prostate cancer cells by downregulating the expression of c‑met
    Yan Shu et al, 2017, Oncology Letters CrossRef
15. Piperlongumine, a potent anticancer phytotherapeutic: Perspectives on contemporary status and future possibilities as an anticancer agent
    Surya Kant Tripathi et al, 2020, Pharmacological Research CrossRef
16. Piperlongumine Inhibits Akt Phosphorylation to Reverse Resistance to Cisplatin in Human Non-Small Cell Lung Cancer Cells via ROS Regulation
    Chao Zhang et al, 2019, Frontiers in Pharmacology CrossRef
17. A Derivative of Piperlongumine and Ligustrazine as a Potential Thioredoxin Reductase Inhibitor in Drug-Resistant Hepatocellular Carcinoma
    Jianqiang Qian et al, 2021, Journal of Natural Products CrossRef
18. Triptolide promotes ferroptosis by suppressing Nrf2 to overcome leukemia cell resistance to doxorubicin
    Xia Wu et al, 2022, Molecular Medicine Reports CrossRef
19. Piperlongumine (piplartine) as a lead compound for anticancer agents – Synthesis and properties of analogues: A mini-review
    Kamil Piska et al, 2018, European Journal of Medicinal Chemistry CrossRef
20. The Potential of Plant-Derived Extracts and Compounds to Augment Anticancer Effects of Chemotherapeutic Drugs
    Chu Xin Ng et al, 2022, Nutrition and Cancer CrossRef